Discover this podcast and so much more

Podcasts are free to enjoy without a subscription. We also offer ebooks, audiobooks, and so much more for just $11.99/month.

D2 Track 2 Session 4: Research does NOT equal a cure - WHAT brings a drug to market?

D2 Track 2 Session 4: Research does NOT equal a cure - WHAT brings a drug to market?

FromThe Eye Believe Podcast


D2 Track 2 Session 4: Research does NOT equal a cure - WHAT brings a drug to market?

FromThe Eye Believe Podcast

ratings:
Length:
62 minutes
Released:
Dec 8, 2023
Format:
Podcast episode

Description

In this session, hear from various experts about what it takes to get a drug to market. The bottom line is that research simply does NOT equal a cure. Learn from some of the best in the uveal melanoma pharma world about the process of bringing a treatment or new drug to market.
Experts include Dr. Katz, Chief Medical Officer at TriSalus Life Sciences; Dr. Wade from Aura Bioscienes, Lucinda Innes, a PHD research student investigating uveal melanoma, and research board member Kevin.
Dr. Steven Katz has been the Chief Medical Officer at TriSalus since September 2020 and is Chairman of the Scientific Advisory Board, which includes leadership of TriSalus’ Translational Immunotherapy Laboratory.
Christian Wade, PhD is a medical affairs leader with over 16 years of experience in the pharmaceutical industry. He is currently the Director of Field Medical Affairs at Aura Biosciences, where he is responsible for leading the field medical affairs team for a portfolio of innovative therapies. Dr. Wade is a graduate of the University of San Francisco and holds a PhD in pharmacology from the University of Washington. He is a member of the Medical Affairs Association and the Pharmaceutical Research and Manufacturers of America.
Lucy was born and raised in Seattle and attended Western Washington University, where she earned her degree in biochemistry. In 2021, she pursued her PhD at Weill Cornell Medicine in New York City. During her first year there, she was diagnosed with Ocular Melanoma. This personal challenge inspired her to redirect her research focus towards the disease. Since her diagnosis in the fall of 2022, Lucy has been delving into the interactions between the immune system and ocular melanoma, aiming to improve the future of immunotherapies.
Email questions to contact@acureinsight.org
ANNOUNCEMENTS:
5K SITES ARE OPEN FOR REGISTRATION NEAR YOU! Start your team and bring your community to get involved! 
November 11, Los Angeles CA
https://runsignup.com/Race/CA/SantaMonica/LookinForACureLosAngeles
November 19, Phoenix, AZ
https://runsignup.com/Race/AZ/Scottsdale/LookinforaCure5k
December 9, Dallas FTW TX
https://runsignup.com/Race/TX/FortWorth/LookinForACureFortWorth
December 10, Houston, TX
https://runsignup.com/Race/TX/Houston/LookinForACureHouston
January 20, 2024 Orlando FL
https://runsignup.com/Race/FL/Orlando/LookinForACureTampa
January 21, 2024, Miami FL
https://runsignup.com/Race/FL/Miami/LookinForACureMiami
Head to our site to register for a 5K Lookin’ for a Cure near you for the remainder of the year!!
www.lookinforacure.org

Subscribe to the newsletter to stay in the know
Newsletter link
Email contact@acureinsight.org for questions regarding any upcoming events!
*********
Be sure to follow us on Facebook, Twitter, Linked In, or  Instagram @acureinsight, for more stories, tips, research news, and ideas to help you navigate this journey with OM!
*A Cure in Sight is a 501c3 organization. All donations made can help fund our podcast to educate patients, fund research, aid patients, and more!

Donate $10 $15 $20 today to help A Cure in Sight in their quest to find a cure.

Contribute via  PAYPAL OR VENMO or reach out directly to contact@acureinsight.org 
Released:
Dec 8, 2023
Format:
Podcast episode

Titles in the series (100)

Sharing information and insights on treatment, research, and living with ocular melanoma.